Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
24.82
+0.82 (3.42%)
At close: Mar 9, 2026, 4:00 PM EDT
24.82
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:34 PM EDT
Arcutis Biotherapeutics Market Cap
Arcutis Biotherapeutics has a market cap or net worth of $3.08 billion as of March 9, 2026. Its market cap has increased by 96.11% in one year.
Market Cap
3.08B
Enterprise Value
2.90B
1-Year Change
96.11%
Ranking
Category
Stock Price
$24.82
Market Cap Chart
Since January 31, 2020, Arcutis Biotherapeutics's market cap has increased from $782.04M to $3.08B, an increase of 293.89%. That is a compound annual growth rate of 25.21%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alumis | 3.35B |
| Spyre Therapeutics | 3.15B |
| Denali Therapeutics | 3.12B |
| Tarsus Pharmaceuticals | 3.12B |
| Edgewise Therapeutics | 2.98B |
| Catalyst Pharmaceuticals | 2.96B |
| IDEAYA Biosciences | 2.91B |
| Viridian Therapeutics | 2.90B |